Androgen receptor
Assets acting on this target.
- Class
- PROTAC androgen receptor degrader
Related mechanisms
Androgen receptor drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Rezvilutamide | Jiangsu Hengrui Pharmaceuticals | small molecule | Phase 3 | Phase 3 in Prostate Cancer |
| Luxdegalutamide | Arvinas Inc., Novartis | protac | Phase 2 | Phase 2 in Metastatic Castration-Resistant Prostate Cancer |